BioSpace News Archive

Three patent families have been filed to cover novel hormonal combinations: pramlintide-exenatide and glucagon-exenatide – both combinations demonstrated promising effects in obesity treatment

The U.S. Food and Drug Administration granted orphan drug designation to Tesomet for the treatment of Prader-Willi syndrome (PWS). This designation qualifies Saniona for certain development benefits, including tax credits, elimination of certain FDA license application fees, and seven years of market exclusivity in the U.S. following approval.

The Treponema pallidum molecule agglutination examine is a circuitous agglutination measure used to identify and titrate antibodies in contrast to the causative specialist of syphilis, called Treponema pallidum which is a subspecies pallidum.

Life science refers to a branch of science that studies organisms and microorganisms. It is an umbrella term of wide range of fields such as cell biology, biotechnology, genetics, molecular biology, biomedicine, and biochemistry.

The global hypodermic needles market is likely to exhibit robust growth. The increasing prevalence of chronic ailments and a rising geriatric population are the key factors boosting the market.

BiPAP, also known as bi-level positive airway pressure therapy, is a type of non-invasive ventilation which involves application of pressure while wearing a mask. The mask is connected to a machine that provides pressure.

Growing use of unique blood biomarkers in the treatment of uveal melanoma fuels the revenue opportunities for the uveal melanoma treatment market

iTeos Therapeutics, Inc., a clinical-stage biopharmaceutical company pioneering the discovery and development of a new generation of highly differentiated immuno-oncology therapeutics for patients, announced that Michel Detheux, PhD, President and Chief Executive Officer, will present at the Jefferies Virtual Healthcare Conference on Wednesday, June 2, 2021 at 8:00 a.m. ET.

iTeos Therapeutics, Inc., a clinical-stage biopharmaceutical company pioneering the discovery and development of a new generation of highly differentiated immuno-oncology therapeutics for patients, announced that Michel Detheux, PhD, President and Chief Executive Officer, will present at the Jefferies Virtual Healthcare Conference on Wednesday, June 2, 2021 at 8:00 a.m. ET.

Tonix Pharmaceuticals Holding Corp. a clinical-stage biopharmaceutical company, announced that it will present two posters at the 2021 American Society of Clinical Psychopharmacology Annual Meeting.